1. Home
  2. BXMT vs LQDA Comparison

BXMT vs LQDA Comparison

Compare BXMT & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Mortgage Trust Inc.

BXMT

Blackstone Mortgage Trust Inc.

HOLD

Current Price

$18.43

Market Cap

3.2B

Sector

Real Estate

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$52.43

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXMT
LQDA
Founded
1966
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.4B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
BXMT
LQDA
Price
$18.43
$52.43
Analyst Decision
Buy
Strong Buy
Analyst Count
5
11
Target Price
$21.38
$41.00
AVG Volume (30 Days)
1.4M
1.2M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
9.85%
N/A
EPS Growth
154.70
51.81
EPS
N/A
0.52
Revenue
N/A
$158,320,000.00
Revenue This Year
N/A
$278.87
Revenue Next Year
N/A
$57.13
P/E Ratio
N/A
$100.97
Revenue Growth
N/A
1031.18
52 Week Low
$17.67
$11.85
52 Week High
$20.67
$53.93

Technical Indicators

Market Signals
Indicator
BXMT
LQDA
Relative Strength Index (RSI) 34.79 81.58
Support Level $18.07 $30.48
Resistance Level $19.10 N/A
Average True Range (ATR) 0.40 2.54
MACD -0.13 1.10
Stochastic Oscillator 1.03 92.14

Price Performance

Historical Comparison
BXMT
LQDA

About BXMT Blackstone Mortgage Trust Inc.

Blackstone Mortgage Trust Inc is an externally managed real estate finance company that originates, acquires, and manages senior loans and other debt or credit-oriented investments collateralized by or relating to commercial real estate in North America, Europe, and Australia. Its portfolio is composed of senior loans secured by high-quality, institutional assets located in main markets, and sponsored by experienced, well-capitalized real estate investment owners and operators. The group finances its investments in a variety of ways, including borrowing under secured credit facilities, issuing collateralized loan obligations, or CLOs, other securitization transactions, syndicating senior loans and/or participations, and other forms of asset-level financing.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: